These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 18793573)
1. Comment on Ibernon et al. Clin Nephrol 2008; 69: 395-401. Stassen PM; Tervaert JW; Stegeman CA Clin Nephrol; 2008 Sep; 70(3):270. PubMed ID: 18793573 [No Abstract] [Full Text] [Related]
2. Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity. Ibernon M; Poveda R; Vidaller A; Bestard O; Grinyó JM Clin Nephrol; 2008 Jun; 69(6):395-401. PubMed ID: 18538114 [TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis. Jones R; Shah S; MacMahon EE; Goldsmith DJ Nephrol Dial Transplant; 2003 Sep; 18(9):1920-2. PubMed ID: 12937244 [No Abstract] [Full Text] [Related]
9. Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis. Stegeman CA Nephrol Dial Transplant; 2002 Dec; 17(12):2077-80. PubMed ID: 12454214 [No Abstract] [Full Text] [Related]
10. [Vasculitis attacking the kidneys]. Grönhagen-Riska C; Teppo AM Duodecim; 1995; 111(15):1442-51. PubMed ID: 9244700 [No Abstract] [Full Text] [Related]
11. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase. Zhang X; Dong Y; Zeng X; Li Y; Tang F Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882 [TBL] [Abstract][Full Text] [Related]
12. Mizoribine induces remission of relapsed ANCA-associated renal vasculitis. Nishioka Y; Horita Y; Tadokoro M; Taura K; Suyama N; Miyazaki M; Harada T; Kohno S Nephrol Dial Transplant; 2006 Apr; 21(4):1087-8. PubMed ID: 16326748 [No Abstract] [Full Text] [Related]
13. Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement. Iatrou C; Zerbala S; Revela I; Spanou E; Marinaki S; Nakopoulou L; Boletis J Clin Nephrol; 2009 Jul; 72(1):31-7. PubMed ID: 19640385 [TBL] [Abstract][Full Text] [Related]
14. Potential immunosuppressive therapeutics to target small vessel vasculitis of the kidney. Williams JM Curr Opin Investig Drugs; 2005 Nov; 6(11):1142-8. PubMed ID: 16312136 [TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement. Hu W; Liu C; Xie H; Chen H; Liu Z; Li L Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810 [TBL] [Abstract][Full Text] [Related]
16. Use of mycophenolic acid in non-transplant renal diseases. Stassen PM; Kallenberg CG; Stegeman CA Nephrol Dial Transplant; 2007 Apr; 22(4):1013-9. PubMed ID: 17307748 [No Abstract] [Full Text] [Related]
17. Subarachnoid hemorrhages in vasculitis. Thompson B; Burns A Am J Kidney Dis; 2003 Sep; 42(3):582-5. PubMed ID: 12955688 [TBL] [Abstract][Full Text] [Related]
18. MPO antibody-positive vasculitis in a patient with psoriatic arthritis and gold-induced membranous glomerulonephritis. Quarenghi MI; Del Vecchio L; Casartelli D; Manunta P; Rossi R Nephrol Dial Transplant; 1998 Aug; 13(8):2104-6. PubMed ID: 9719174 [No Abstract] [Full Text] [Related]